About
Nepsita 50/500 is a combination medication containing Vildagliptin (50mg) and Metformin (500mg), indicated for the management of type 2 diabetes mellitus. Metformin, a biguanide, works by reducing hepatic glucose production, decreasing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues. Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the body's natural ability to control blood glucose by increasing the levels of active incretin hormones (GLP-1 and GIP).
These incretins stimulate insulin release from pancreatic beta cells and suppress glucagon secretion from alpha cells in a glucose-dependent manner, leading to improved glycemic control. The synergistic action of Vildagliptin and Metformin addresses multiple pathophysiological defects of type 2 diabetes, providing comprehensive blood glucose lowering effects and helping to achieve target HbA1c levels when monotherapy is insufficient.
Uses
- Management of type 2 diabetes mellitus.
- As an adjunct to diet and exercise.
- When metformin monotherapy is insufficient.
- To improve glycemic control in adults.
Directions For Use
Take orally with meals to minimize gastrointestinal side effects. Follow your doctor's prescribed dosage and schedule.
Benefits
- Provides effective glycemic control.
- Reduces both fasting and post-meal blood sugar.
- Lowers HbA1c levels significantly.
- Offers a dual mechanism of action.
- Generally well-tolerated.
- May have a low risk of hypoglycemia.
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Metallic taste
- Headache
- Dizziness
- Nasopharyngitis
- Tremor
- Fatigue
- Hypoglycemia (rare)
- Lactic acidosis (rare, serious)
Safety Measures
- Alcohol - Avoid excessive alcohol intake due to an increased risk of lactic acidosis, especially with metformin.
- Pregnancy - Generally not recommended during pregnancy unless the potential benefits outweigh the risks. Consult your doctor.
- Breastfeeding - Metformin passes into breast milk; vildagliptin data is limited. Consult a healthcare professional before use.
- Liver - Use with caution; metformin is contraindicated in severe hepatic impairment. Vildagliptin is not recommended in moderate to severe impairment.
- Kidney - Dose adjustment is required; contraindicated in severe renal impairment due to metformin accumulation and increased risk of lactic acidosis.
- Lung - No specific contraindication, but caution is advised in severe respiratory conditions that may increase the risk of acidosis.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!